BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240307T110000
DTEND;TZID=America/New_York:20240307T120000
DTSTAMP:20260503T123427
CREATED:20240207T185132Z
LAST-MODIFIED:20241024T183019Z
UID:10000726-1709809200-1709812800@staging.digitalinsights.supremeclients.com
SUMMARY:Using COSMIC to predict\, identify\, and avoid mutational consequences of cancer therapies during early drug development and in patients
DESCRIPTION:Whether your lab is researching and developing targeted cancer therapies or you are analyzing and interpreting diagnostic tests at the point-of-care\, a critical part of your workflow is understanding the structural and functional impact of cancer-related mutations. \nThe Catalogue Of Somatic Mutations In Cancer (COSMIC) is an expert-curated database encompassing a wide variety of somatic mutation mechanisms causing human cancer. Containing more than 24 million somatic variants with detailed information on mutation distribution\, effects\, and signatures\, COSMIC helps users better predict the cancer-driving effects of mutations and identify available drugs that target specific variants. COSMIC continues to expand its utility with continuous updates to its Mutational Signatures\, the Cancer Mutation Census\, and Mutation Actionability in Precision Oncology products. \nTo illustrate key applications of these features\, this webinar will focus on how COSMIC can be used to avoid mutational consequences in cancer drug development and to detect mutational consequences of therapies in clinical diagnostics. \nThrough these clinical and discovery use cases\, attendees will: \n\nLearn how to use COSMIC to identify and prioritize coding and non-coding mutational hotspots\nUnderstand how COSMIC helps determine actionability of clinically approved homologous recombination deficiency signatures\nExplore future uses of non-coding and signature-based COSMIC content for drug development and potential clinical diagnostic applications
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/using-cosmic-to-predict-identify-and-avoid-mutational-consequences-of-cancer-therapies-during-early-drug-development-and-in-patients-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/QPRO-6076_WEBINAR_QCI_COSMIC_DrugDevelopment_16x9-002.jpg
END:VEVENT
END:VCALENDAR